TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin.
Jones, R Crabb, S Chester, J Huddart, R Birtle, A Evans, L Lester, J Huang, C Casbard, A
Jones, R
Crabb, S
Chester, J
Huddart, R
Birtle, A
Evans, L
Lester, J
Huang, C
Casbard, A
Citations
Altmetric:
Abstract
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin. 2016, 34(2):448 J Clin Oncol